Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Current Liabilities ₹973 Cr₹683 Cr₹710 Cr₹526 Cr₹685 Cr

What is the latest Total Current Liabilities ratio of NATCO PHARMA ?

The latest Total Current Liabilities ratio of NATCO PHARMA is ₹973 Cr based on Mar2024 Consolidated results.
Year Total Current Liabilities
Mar2024₹973 Cr
Mar2023₹683 Cr
Mar2022₹710 Cr
Mar2021₹526 Cr
Mar2020₹685 Cr

How is Total Current Liabilities of NATCO PHARMA Trending?

Years Total Current Liabilities % Change
Mar2024 ₹973 Cr
42.41
Mar2023 ₹683 Cr
-3.84
Mar2022 ₹710 Cr
35.16
Mar2021 ₹526 Cr
-23.30
Mar2020 ₹685 Cr -

Compare Total Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,823.5 Cr 4.5% 7.1% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.5%

7.1%

-11.6%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses